期刊文献+

连花清瘟颗粒治疗54例新型冠状病毒肺炎患者临床分析及典型病例报道 被引量:80

Clinical Effectiveness and Case Analysis in 54 NCP Patients Treated with Lanhuaqingwen Granules
下载PDF
导出
摘要 目的:分析连花清瘟颗粒治疗新型冠状病毒肺炎的临床疗效。方法:选取2020年1月1-31日在武汉科技大学附属普仁医院就诊的,应用连花清瘟颗粒联合常规治疗(根据病情监测给予营养支持治疗、抗病毒治疗及抗菌药物治疗等)的新型冠状病毒肺炎患者54例作为研究对象。结果:应用连花清瘟颗粒治疗3 d后,发热、乏力、咳嗽症状消失率分别为47.5%、35.1%、20.0%,治疗5 d后发热、乏力、咳嗽症状消失率分别为62.5%、59.5%、50.0%,治疗7 d后发热、乏力、咳嗽症状消失率分别为80.0%、75.7%、76.7%;发热、乏力、咳嗽消失天数分别为(3.6±2.14)d、(4.1±2.58)d、(5.3±2.63)d;治疗7 d后,其他症状体征(胸闷、呼吸困难、湿啰音)消失率分别为84.6%、100%、89.5%;有效率为81.6%,且临床应用安全性良好。结论:连花清瘟颗粒明显改善新型冠状病毒肺炎普通型患者发热、咳嗽、乏力等症状,减少发热、乏力、咳嗽持续天数,为临床治疗该病提供初步研究证据。 Objective:To analyze the clinical effectiveness of Lianhuaqingwen Granules(LH-C)novel coronavirus pneumonia(NCP)patients.Methods:The clinical data of 54 ordinary NCP patients were retrospectively analyzed at the Puren affiliated Hospital of Wuhan University of Science and Technology.Results:After treatment with LH-C for three consecutive days,the rate of symptoms disappearance in fever,weakness,and cough was 47.5%,35.1%,and 20%,respectively.Five days later,the rate of symptoms disappearance in fever,weakness,and cough increased to 62.5%,59.5%,and 50.0%,respectively.By the seventh day,the rate of symptoms disappearance in fever,weakness,and cough reached 80.0%,75.7%,and 76.7%.The days of symptoms disappearance in fever,weakness,and cough was(3.6±2.14)d,(4.1±2.58)d,and(5.3±2.63)d.As regards the other symptom,the rate of symptoms disappearance in the chest stuffiness,the dyspnea,and the moist crackles was 84.6%,100%,and 89.5%,and the total efficiency was up to 81.6% without any observed side effects by the seventh day.Conclusion:LH-C could significantly relieve clinical symptoms in ordinary NCP patients by inhibiting fever,weakness,and cough,and reducing their duration.All these results provided preliminary clinical evidence for LH-C in the NCP treatment.
作者 程德忠 李毅 CHENG Dezhong;LI Yi(The Puren affiliated Hospital of Wuhan University of Science and Technology,Wuhan 430081,China)
出处 《世界中医药》 CAS 2020年第2期150-154,共5页 World Chinese Medicine
关键词 连花清瘟 新型冠状病毒 新型冠状病毒肺炎 临床疗效 回顾性分析 典型病例 Lianhuaqingwen 2019-nCoV NCP Clinical efficacy Retrospective analysis Typical cases
  • 相关文献

参考文献4

二级参考文献22

  • 1杨立波,季振慧,高学东,谷春华.连花清瘟胶囊治疗流行性感冒Ⅱ期临床研究[J].中药新药与临床药理,2005,16(4):290-293. 被引量:44
  • 2张庆宏,杨进,龚婕宁,郭海.连花清瘟胶囊对内毒素致热家兔体温的影响[J].辽宁中医药大学学报,2007,9(1):44-45. 被引量:14
  • 3莫红缨,柯昌文,郑劲平,钟南山.连花清瘟胶囊体外抗甲型流感病毒的实验研究[J].中药新药与临床药理,2007,18(1):5-9. 被引量:107
  • 4郭利民 徐道振.SARS的抗病毒治疗[N].中国医学论坛报,2003—07—10.
  • 5刘玲.中西医结合是治疗SARS的最佳选择[N].中国医学论坛报,2003—06—26.
  • 6中华人民拭和国卫生部.甲型HINt流感诊疗方案(2009年试行饭第二版)[OL].[2009-07-03j.http://www.mob.gov.cn.
  • 7齐文升,何龙,杨秀捷,等.连花清瘟胶囊治疗流行性感冒临床试验[N].中国医学论坛报,2005-03-10(17).
  • 8Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome[J]. N Engl J Med, 2003,348(20):1967.
  • 9Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome [J]. N Engl J Med, 2003,348(20):1953.
  • 10Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome[J]. Lancet, 2003,361(9366):1319.

共引文献187

同被引文献1069

引证文献80

二级引证文献666

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部